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        Introduction 
  Angiogenesis is of critical importance to blood vessel formation 
in developing embryos and in physiological and pathological 
conditions (for reviews see   Risau, 1997; Coultas et al., 2005  ). 
During angiogenesis, endothelial cells respond to both prolifer-
ative signals and morphogenetic cues to extend simple vascular 
structures and form and expand a branching plexus. Although 
several signaling pathways important in angiogenesis have been 
identifi  ed, relatively little is known about how these signals are 
regulated to coordinate vessel branching and endothelial cell 
proliferation. 
 The VEGF-A signaling pathway is a crucial mediator of endo-
thelial cell division and migration during angiogenesis (for reviews 
see   Kowanetz and Ferrara, 2006  ;   Shibuya and Claesson-Welsh, 
2006  ). The VEGF-A pathway requires tight dose-dependent 
regulation for proper blood vessel formation because minor 
changes in the amount of VEGF-A adversely affect vascular 
development, and the loss of even one copy of the   vegfa   gene 
leads to embryonic lethality (  Carmeliet et al., 1996 ;   Ferrara et al., 
1996  ;   Bautch et al., 2000  ;   Miquerol et al., 2000  ). VEGF-A sig-
naling is modulated by alternative splicing of VEGF-A RNA 
to produce three major isoforms (  Tischer et al., 1991  ). These 
VEGF-A isoforms have differing affi  nities for heparin that 
are predicted to lead to differential distribution from VEGF-A  –
  producing cells, and genetic manipulation of these isoforms 
leads to vessel dysmorphogenesis (  Ruhrberg et al., 2002  ; 
 Stalmans  et  al., 2002  ). Recent studies by   Gerhardt et al. (2003)   
support a model in which the spatial context of VEGF-A ligand 
presentation to the endothelial cell is important for vessel mor-
phogenesis, whereas endothelial cell proliferation is regulated 
by the local VEGF-A concentration in a spatially indepen-
dent manner. 
  The biological effects of VEGF-A are mediated by two 
high affi  nity receptor tyrosine kinases expressed on endothe-
lial cells: fl  k-1 (VEGFR-2) and fl  t-1 (VEGFR-1). VEGF-A 
signaling through fl  k-1 positively regulates endothelial cell di-
vision and migration, whereas the function of fl  t-1 is less clear 
(for reviews see   Rahimi, 2006  ;   Shibuya, 2006  ). Deletion of 
  B
lood vessel formation requires the integrated regu-
lation of endothelial cell proliferation and branch-
ing morphogenesis, but how this coordinated 
regulation is achieved is not well understood. Flt-1 (vas-
cular endothelial growth factor [VEGF] receptor 1) is a 
high afﬁ  nity VEGF-A receptor whose loss leads to vessel 
overgrowth and dysmorphogenesis. We examined the 
ability of Flt-1 isoform transgenes to rescue the vascular 
development of embryonic stem cell  –  derived   ﬂ  t-1 
    /        mu-
tant vessels. Endothelial proliferation was equivalently 
rescued by both soluble (sFlt-1) and membrane-tethered 
(mFlt-1) isoforms, but only sFlt-1 rescued vessel branching. 
Flk-1 Tyr-1173 phosphorylation was increased in   ﬂ  t-1 
    /        
mutant vessels and partially rescued by the Flt-1 isoform 
transgenes. sFlt-1  –  rescued vessels exhibited more hetero-
geneous levels of pFlk than did mFlt-1  –  rescued vessels, 
and reporter gene expression from the   ﬂ  t-1   locus was 
also heterogeneous in developing vessels. Our data sup-
port a model whereby sFlt-1 protein is more efﬁ  cient than 
mFlt-1 at amplifying initial expression differences, and 
these ampliﬁ  ed differences set up local discontinuities in 
VEGF-A ligand availability that are important for proper 
vessel branching.
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We found soluble Flt-1 to be highly effective at rescuing branch-
ing morphogenesis relative to membrane-bound Flt-1, whereas 
both membrane-tethered and soluble Flt-1 rescued endothelial 
cell proliferation equivalently. Moreover, expression from the 
  fl  t-1   locus was heterogeneous in developing vessels, and the 
level of Flk-1 phosphorylation on individual endothelial cells in 
developing vessels was more heterogeneous in sFlt-1  –  rescued 
vessels than in mFlt-1  –  rescued vessels, suggesting that sFlt-
regulated spatial discontinuities in Flk-1 signaling derived from 
heterogeneous   fl  t-1   locus expression are required for proper 
branching morphogenesis. Our results support a model in which 
VEGF-A ligand presentation is modulated by Flt-1 isoform 
production in the target endothelial cells to ensure proper 
vessel morphogenesis. 
  Results 
  Both ﬂ  t-1 isoforms are expressed in 
developing blood vessels 
  To determine the relative expression levels of Flt-1 (VEGFR-1) 
isoforms during vascular development, we used real-time PCR 
with isoform-specifi  c primers for sFlt-1 or mFlt-1 (  Fig. 1  ; 
  Hazarika et al., 2007  ). This analysis showed that, as expected, 
the expression levels of both isoforms were increased over the 
time course of development of ES cell  –  derived vessels (  Fig. 1 A  ). 
Moreover, comparison showed that the relative proportions of 
each isoform were roughly equivalent and that the relative pro-
portions did not signifi  cantly change during the time course of 
differentiation (  Fig. 1 B  ). These data indicate that both sFlt-1 
and mFlt-1 are expressed during vascular development and pro-
vide a rationale for investigating the effects of each isoform on 
vascular development. 
  Transgenes encoding individual Flt-1 
isoforms targeted into the ROSA26 locus 
rescue the   ﬂ  t-1 
    /         vessel phenotype 
  ES cell  –  derived vessels lacking both Flt-1 isoforms have an in-
creased endothelial cell mitotic index (  Kearney et al., 2002  ) 
and a morphogenetic defect that results in reduced sprouting 
and branch formation (  Kearney et al., 2004  ). To directly assess 
the role of the soluble (sFlt-1) and membrane-bound (mFlt-1) 
Flt-1 isoforms on endothelial cell division and vessel morpho-
genesis, we targeted sFlt-1 and mFlt-1 isoform transgenes linked 
to the platelet endothelial cell adhesion molecule (PECAM) 
promoter/enhancer into the   ROSA26   genomic locus of   fl  t-1 
   /      
ES cells (  Fig. 2  ). Transgenes targeted to the   ROSA26   locus of 
ES cells are present as a single copy rather than long concata-
mers, and they have uniform expression levels (  Soriano, 1999  ; 
  Srinivas et al., 2001  ). This strategy allowed for the direct com-
parison of rescue properties of the sFlt-1 and mFlt-1 isoform 
transgenes. The transgenes were linked to the PECAM pro-
moter/enhancer because this regulatory region results in the 
expression of transgenes in developing blood vessels (  Kearney 
et al., 2004  ). After electroporation of the targeting constructs, 
drug-resistant   fl  t-1 
   /       ES colonies were selected, and correct 
targeting by homologous recombination was confi  rmed by PCR 
(unpublished data). 
  fl  t-1   in mice results in embryonic lethality at midgestation 
with vascular defects, and deletion of   fl  t-1   in mouse embry-
onic stem (ES) cell  –  derived vessels leads to the overprolifera-
tion of endothelial cells and dysmorphogenesis of vessels 
(  Fong et al., 1995  ;   Kearney et al., 2002, 2004  ). Flt-1 mRNA is 
alternatively spliced to encode both a full-length receptor ty-
rosine kinase (mFlt-1) and a soluble isoform (sFlt-1) that con-
tains the VEGF-A  –  binding extracellular domain (  Kendall and 
Thomas, 1993  ). VEGF-A has a higher affi  nity for Flt-1 than 
for Flk-1, so both Flt-1 isoforms can potentially sequester 
VEGF-A and modulate signaling through Flk-1.   Flt-1 
   /       ES 
cell  –  derived vessels have approximately threefold higher lev-
els of activated Flk-1 than do normal vessels as measured by 
overall levels of tyrosine phosphorylation, which is consistent 
with a role for Flt-1 in ligand sequestration during develop-
ment (  Roberts et al., 2004  ). Moreover, mice lacking the cyto-
plasmic tail of the Flt-1 receptor are viable, indicating that the 
signaling function of Flt-1 is not essential during embryonic 
development (  Hiratsuka et al., 1998  ). Collectively, these data 
suggest that Flt-1 functions in vascular development as a li-
gand sink to bind and sequester VEGF-A, and in this way Flt-1 
regulates signaling through the Flk-1 receptor. However, how 
the two Flt-1 isoforms contribute to this regulation has not 
been elucidated. 
  We hypothesized that the Flt-1 isoforms have differential 
effects on endothelial proliferation and branching morphogene-
sis in developing vessels. To test this hypothesis, we reintro-
duced isoform-specifi  c Flt-1 transgenes into   fl  t-1 
   /       vessels. 
  Figure 1.       Flt-1 isoform expression during a developmental time course.   
WT ES cell cultures were used (day 0) or differentiated for the indicated 
number of days, and total RNA was isolated for real-time PCR analysis. 
(A) The relative copy number of sFlt-1 or mFlt-1 RNAs were calculated rela-
tive to 18S RNA. (B) The ratio of sFlt-1/mFlt-1 RNA over time. Error bars 
represent SEM.     849  F  LT  -1 REGULATES VESSEL BRACHING SPATIALLY   •   Kappas et al.
et al., 2002  ). Compared with controls (wild-type [WT] mean = 
16.5%;   fl  t-1 
   /       mean = 53.4%), all rescue clones partially rescued 
vessel area (sFlt rescue mean = 24.2%; mFlt rescue mean = 
24.1%), and no consistent differences were seen between the 
groups of sFlt-1 and mFlt-1 rescue clones (  Fig. 4 A  ). In con-
trast, analysis of vessel morphogenesis by branch point analysis 
showed that compared with controls (WT mean = 12.6 branches/
millimeter;   fl  t-1 
   /       mean = 7.8 branches/millimeter), sFlt-1 rescue 
clones signifi  cantly rescued branching (sFlt rescue mean = 
9.8 branches/millimeter), whereas the group of mFlt-1 res-
cue clones did not signifi  cantly rescue branching (mFlt rescue 
mean = 8.2 branches/millimeter;   Fig. 4 B  ). Thus, the   ROSA26  
locus  –  targeted clones exhibited differential rescue effects on 
the   fl  t-1 
   /       mutant vessels; vessel area was equivalently rescued 
by both Flt-1 isoforms, whereas vessel morphogenesis was only 
rescued by the sFlt-1 isoform. 
  To further verify that the changes in vessel area refl  ected 
the rescue of endothelial proliferation, we analyzed a subset of 
each group of Flt-1 isoform rescue clones for two additional pa-
rameters. We performed FACS analysis for an independent 
endothelial marker, ICAM-2, and found a similar pattern in that 
all analyzed Flt-1 rescue clones had endothelial cell numbers 
that were intermediate between Flt-1 mutant vessels and WT 
vessels (Fig. S1, available at http://www.jcb.org/cgi/content/full/
jcb.200709114/DC1). Next, we calculated the endothelial mi-
totic index for the same subset of rescue clones and found that 
all Flt-1 isoform rescue clones had endothelial mitotic indices at 
or near that of WT vessels and signifi  cantly different from that 
of   fl  t-1 
   /       mutant vessels (  Fig. 5  ). Thus, all Flt-1 isoform rescue 
clones had a partial rescue of vessel area, the number of endo-
thelial cells, and the endothelial mitotic index relative to   fl  t-1 
   /      
  From a group of 10  –  15 rescue clones with each isoform, we 
selected four clones each of the ROSA26sFlt-1 and ROSA26mFlt-1 
genotype for further analysis. These   fl  t-1 
   /      
;Tg PECAM-flt-1ROSA  
ES cell clones were differentiated to day 8, and the expression 
of individual Flt-1 isoform transgenes was verifi  ed by RT-PCR, 
showing little heterogeneity in expression levels from the 
  ROSA26   locus (  Fig. 2 C  ). The differentiated cultures were also 
labeled with PECAM antibody to visualize developing blood 
vessels (  Fig. 3  ). Compared with   fl  t-1 
   /       cultures, all Flt-1 iso-
form transgene clones showed a partial rescue of vascular develop-
ment (  Fig. 3,   compare A and B with C  –  J). The rescue clones 
had fewer areas of overt vessel dysmorphogenesis and endo-
thelial sheets and more areas of branching. Thus, targeting of 
PECAM promoter/enhancer-driven Flt-1 isoform transgenes 
to the ROSA26 genomic locus leads to rescue of the   fl  t-1 
   /      
mutant vessel phenotype. 
  Isoform-speciﬁ  c differences in rescue 
phenotypes of Flt-1 transgenes 
  Close visual inspection of the Flt-1 isoform transgene rescue 
clones suggested isoform-specifi  c differences in the rescue phe-
notypes (  Fig. 3  ). Specifi  cally, although the rescue of vessel area 
appeared similar in all clones, the group of sFlt-1 isoform rescue 
clones had a rescue of branching morphogenesis that was not 
seen in the mFlt-1 isoform rescue clones (  Fig. 3,   compare C  –  F 
with G  –  J). To quantify the Flt-1 isoform rescue phenotypes, 
PECAM-stained cultures were analyzed for the percentage of 
vessel area, as measured by the PECAM-positive area relative 
to the total cellular area of the culture (  Fig. 4 A  ). We previously 
showed that this parameter refl  ects the endothelial mitotic index 
and is thus a measure of endothelial cell proliferation (  Kearney 
  Figure 2.         ROSA26   locus  –  targeted Flt-1 iso-
form rescue clones.   (A) Flt-1 isoform transgene 
  ROSA26   targeting. (top) Restriction map of the 
  ROSA26   locus. (middle) pROSA26-1  –  contain-
ing insertion cassette of PECAM promoter/
enhancer, Flt-1 isoform, and a hygromycin B 
selectable marker with PGK  –  diptheria toxin A 
cassette for negative selection. (bottom) Pre-
dicted structure of the   ROSA26   locus after in-
tegration of the pROSA26-1 insertion cassette 
in   ﬂ  t-1 
    /        ES cells. Arrows denote primers used 
to verify correct targeting into   ﬂ  t-1 
    /        ES cells 
(not depicted). (B) Diagram of individual Flt-1 
isoforms. Soluble Flt-1 (sFlt-1) and membrane-
localized Flt-1 (mFlt-1) each contain an extra-
cellular VEGF-A  –  binding domain consisting of 
Ig domains (gray circles). Only mFlt-1 contains 
a transmembrane domain region (TM) and a 
tyrosine kinase domain. (C) Total RNA was iso-
lated from differentiated day 8 wild-type (WT), 
  ﬂ  t-1 
    /       ,   ﬂ  t-1 
    /        
;Tg ROSA-PECAM-sﬂ   t-1  , and   ﬂ  t-1 
    /        
;Tg 
ROSA-PECAM-mﬂ  t-1   cultures and analyzed by semi-
quantitative RT-PCR using   ﬂ  t-1   primers.     JCB • VOLUME 181 • NUMBER 5 • 2008  850 
Flk-1 Tyr-1173 (equivalent to Tyr-1175 in VEGFR-2;   Fig. 6  ) 
because this tyrosine is essential for blood vessel formation and 
embryonic viability (  Sakurai et al., 2005  ). Analysis of the level 
of Flk-1 Tyr-1173 phosphorylation (pFlk) relative to total Flk-1 
by Western blotting showed the expected increase in the ratio 
for the Flt-1 mutant culture, and the ROSA locus  –  targeted Flt-1 
isoform rescue clones had ratios largely intermediate between 
mutant and WT cultures (  Fig. 6, A and B  ). 
  Differentiated ES cell cultures were double stained for 
total Flk-1 and pFlk and examined by confocal microscopy 
(  Fig. 7  ). The Flk-1  –  positive cells were scored as being positive 
or negative for pFlk (  Fig. 7, A and B  ). Consistent with the 
results of the Western blot, the confocal analysis showed that 
a higher proportion of Flk-1  –  expressing cells were positive 
for pFlk in   fl  t-1 
   /       mutant vessels (30%) compared with WT 
vessels (17%), and the   ROSA26   locus – targeted  Flt-1  isoform 
mutant cultures, showing that all   ROSA26   locus – targeted  rescue 
clones partially rescue endothelial cell proliferation. 
  Flt-1 isoform transgenes modulate 
signaling through the Flk-1 receptor 
  Tyrosine phosphorylation of the Flk-1 receptor is increased in 
the absence of Flt-1, consistent with a model in which Flt-1 
normally negatively modulates signaling through Flk-1 (  Roberts 
et al., 2004  ). To determine how the Flt-1 isoforms affected sig-
naling through Flk-1, we assayed specifi  c phosphorylation at 
  Figure 3.         ROSA26  -targeted Flt-1 isoforms rescue   ﬂ  t-1 
    /        mutant ves-
sel dysmorphogenesis.   Day 8 differentiated ES cultures were stained for 
PECAM. All transgenic clones partially rescued the vessel dysmorphogen-
esis of   ﬂ  t-1 
    /        vessels (B). Note that targeted sFlt-1 transgene   ROSA26   
clones (C  –  F) appear to have more branched vessels than do targeted mFlt-1 
transgene   ROSA26   clones (G  –  J). Clone numbers are indicated in the top 
right of each frame. Bar, 200   μ  m.     
  Figure 4.         ROSA26  -targeted Flt-1 isoforms differentially rescue   ﬂ  t-1 
    /        
mutant vessel parameters.   (A and B) Day 8 differentiated ES cell cultures 
were reacted with the PECAM antibody, and representative areas were 
analyzed for vessel area (A) or branch point frequency (B). (A) The mean 
vessel area of all rescue clones was signiﬁ  cantly different from WT and 
  ﬂ t - 1  
    /        mutant clones (  ﬂ  t-1 
    /        vs. sFlt and mFlt, P   ≤   0.0005; WT vs. sFlt and 
mFlt, P   ≤   0.02) but did not differ between sFlt-1 and mFlt-1 rescue clones 
(sFlt vs. mFlt, P = 0.86). (B) The mean branch points/millimeter vessel length 
was signiﬁ  cantly different between sFlt-1 and mFlt-1 rescue clones (sFlt vs. 
mFlt, **, P   ≤   0.03). Branch points/millimeter vessel length was not signiﬁ  -
cantly different between   ﬂ  t-1 
    /        mutant and mFlt clones (  ﬂ  t-1 
    /        vs. mFlt, 
P = 0.97; WT vs. mFlt, P   ≤   0.01). Branch points/millimeter vessel length 
was signiﬁ  cantly different between   ﬂ  t-1 
    /        mutant and sFlt isoform clones 
(  ﬂ  t-1 
    /        vs. sFlt, P   ≤   0.01; WT vs. sFlt, P = 0.16). Error bars represent SEM.     851  F  LT  -1 REGULATES VESSEL BRACHING SPATIALLY   •   Kappas et al.
  However, visual examination of the pFlk/total Flk double-
stained vessels in the different   fl  t-1   genetic backgrounds sug-
gested that the pFlk staining patterns differed ( Fig. 7 A ). In a given 
vessel that was Flk-1 positive, WT vessels showed a mosaic pat-
tern of pFlk staining, with some cells showing a relatively strong 
pFlk signal relative to other cells in the same vessel (  Fig. 7 A  , a  –  d). 
In contrast,   fl  t-1 
   /       mutant vessels had more uniform pFlk-1 
staining along a given Flk-1  –  positive vessel (  Fig. 7 A  , e  –  h). The 
  ROSA26   locus – targeted  sFlt-1 – rescued  vessels  showed  a  similar 
mosaic pattern of pFlk staining as seen in the WT vessels, whereas 
the mFlt-1  –  rescued vessels resembled the   fl  t-1 
   /       mutant  vessels 
in having a more homogeneous pattern of pFlk staining (  Fig. 7 A  , 
i  –  p). To quantify these results, double-stained pFlk/total Flk-
positive endothelial cells in vessels were analyzed using imaging 
software to determine individual ratios of pFlk to total Flk signal 
(  Fig. 7 C  ). The distribution of ratios was very similar in WT and 
sFlt-1  –  rescued vessels. For example, only 8.0% (2/25) of WT and 
8.3% (2/24) of sFltR18 endothelial cells had pFlk/total Flk ratios 
between 0.2 and 0.3. In contrast,   fl  t-1 
   /       mutant vessels and 
mFlt-1  –  rescued vessels had a different distribution of ratios. In 
these genetic backgrounds, 48% (12/25) of   fl  t-1 
   /       mutant  and 
33% (7/21) of mFltR23 endothelial cells had pFlk/total Flk ratios 
between 0.2 and 0.3. These fi  ndings suggest that the mosaic dis-
tribution of Flk-1 signaling in endothelial cells is important for 
proper vascular morphogenesis and that the sFlt-1 isoform but not 
the mFlt-1 isoform rescues this aspect of VEGF signaling. 
rescue clones had values that were largely intermediate between 
the two controls (  Fig. 7 B  ). Neither analysis showed consistent 
differences between the sFlt-1  –  rescued vessels and the mFlt-1  –
 rescued  vessels. 
  Figure 5.         ROSA26  -targeted Flt-1 isoform transgenes partially rescue the 
endothelial cell mitotic index.   (A  –  F) Day 7 differentiated cultures were ﬁ  xed 
and stained for PECAM-1 (green), the mitotic marker antiphosphohistone H3 
(red), and the nuclear dye DRAQ 5 (blue). (G) Representative confocal images 
were scored by counting the PECAM-positive nuclei and the percentage that 
reacted with the phosphohistone antibody to calculate the endothelial mitotic 
index. Error bars represent SEM.       
2   analysis showed that the WT endothelial 
mitotic index was signiﬁ  cantly different from   ﬂ  t-1 
    /        mutants (      
2   = 15.1; P   ≤   
0.0001), and each of the Flt-1 isoform rescue clones differed from   ﬂ  t-1 
    /        mu-
tants (sFltR1:       
2   = 12.2; P   ≤   0.0005; sFltR18:       
2   =7.6; P   ≤   0.005; mFltR23: 
      
2   = 7.5; P   ≤   0.008; mFltR25:       
2   = 13.0; P   ≤   0.0003). Bar, 50   μ  m.     
  Figure 6.         ROSA26  -targeted Flt-1 isoform transgenes partially rescue the 
ratio of pFlk to total Flk-1.   Day 8 differentiated cultures were processed 
for Western blot analysis with antibodies to total Flk-1 and pFlk (Tyr-
1173/1175). (A, top) The signal from hybridization with pFlk antibody. 
(bottom) Hybridization with a total Flk-1 antibody. All rescue clones tested 
partially rescued the increased pFlk signal seen in the   ﬂ  t-1 
    /        mutant cul-
tures (compare lane 2 with lanes 3  –  6). (B) Quantitation of the normalized 
signals from a representative experiment.     JCB • VOLUME 181 • NUMBER 5 • 2008  852 
pression varied quite dramatically in areas of   fl  t-1 
   /       vessels, with 
some cells having strong staining relative to nearby cells with little 
to no staining (  Fig. 8, A  –  H  ). To verify that expression differences 
also existed in a nonmutant background, we examined phenotypi-
cally normal  fl  t-1 
+/       vessels and found evidence of heterogeneity in 
  To begin to determine how sFlt-1 expression leads to hetero-
geneity of the pFlk signal, we examined reporter gene expression 
from the   fl  t-1   locus in developing vessels using readout of the   lacZ  
gene inserted into the   fl  t-1   locus in   fl  t-1 
+/        and   fl  t-1 
   /       ES cell  – 
derived vessels (  Fig. 8  ). The levels of      -galactosidase reporter ex-
  Figure 7.         ROSA26  -targeted sFlt-1 isoform transgene preferentially rescues the mosaic endothelial expression of pFlk (Tyr-1173).   Day 8 differentiated cultures 
were ﬁ  xed and stained with antibodies to total Flk-1 and pFlk (Tyr-1173/1175). (A) ES-derived vessels were visualized by staining for pFlk in green (a, e, I, and m), 
total Flk in red (b, f, j, and n), and DRAQ 5 in blue to visualize nuclei (c, g, k, and o). In a  –  c, e  –  g, i  –  k, and m-o, red asterisks denote endothelial cells with 
moderate to high levels of pFlk, and yellow asterisks denote endothelial cells with none to low levels of pFlk. Note that pFlk-positive endothelial cells are mosaic 
in WT (a  –  d), and   ﬂ  t-1 
    /        endothelial cells have more uniform high levels of pFlk (e  –  h). Expression of the sFlt-1 transgene (i  –  l) recreates the heterogeneous pat-
tern of pFlk vessel staining, whereas expression of the mFlt-1 transgene (m  –  p) does not lead to heterogeneity of staining. (B) Stained cultures were visualized 
for total Flk, and the same cells were scored as positive or negative for pFlk. Percentages of a representative experiment are shown on the y axis. (C) Individual 
endothelial cells were outlined and analyzed for the ratio of pFlk/total Flk using imaging software. The numbers were graphed in order of descending ratios 
for each genotype. In each graph, the darker areas show the number of cells that had pFlk/total Flk ratios between 0.2 and 0.3. Bar, 10   μ  m.     853  F  LT  -1 REGULATES VESSEL BRACHING SPATIALLY   •   Kappas et al.
uble and membrane-localized Flt-1 isoform transgenes rescue 
endothelial proliferation to equivalent levels, but they affect 
branching morphogenesis in different ways. The soluble Flt-1 
isoform transgene but not the membrane-tethered Flt-1 isoform 
transgene rescues vessel branching morphogenesis, and the dif-
ferent branching rescue phenotypes correlate with different pat-
terns of Flk-1 activation in developing vessels. These fi  ndings 
suggest that the ability of sFlt-1 to bind and sequester VEGF-A at 
a distance from the endothelial cell surface is important for proper 
vessel morphogenesis, and, thus, endothelial cells of developing 
vessels provide critical input for their own morphogenesis. 
reporter gene expression levels among nearby endothelial cells in 
developing vessels (  Fig. 8, I  –  P  ). These fi  ndings suggest that Flt-1 
RNA is expressed heterogeneously from the   fl  t-1   locus and that 
initial differences in   fl  t-1   locus expression are differentially ampli-
fi  ed by sFlt-1 protein over mFlt-1 protein, leading to the observed 
heterogeneity of pFlk staining seen in the sFlt-1  –  rescued vessels. 
  Discussion 
  Our results show that two Flt-1 isoforms produced by endothelial 
cells have differential effects on developing vessels. Both the sol-
  Figure 8.       Expression of     -galactosidase from the   ﬂ  t-1   locus reveals heterogenous endothelial cell expression in developing vessels.   Day 8 differentiated 
cultures were ﬁ  xed and stained with antibodies to      -galactosidase and PECAM-1. (A  –  H)   ﬂ  t-1 
    /        mutant vessels. (I  –  P)   ﬂ  t-1 
+/        heterozygous (phenotypically 
normal) vessels. ES-derived vessels were visualized by staining for      -galactosidase in red (A, E, I, and M), PECAM-1 in green (B, F, J, and N), and DRAQ 5 
in blue to visualize nuclei (C, G, K, and O). In A, E, I, and M, red arrows denote endothelial cells with moderate to high levels of      -galactosidase, and red 
arrowheads denote endothelial cells with none to low levels of      -galactosidase. All panels are z-stack compilations of 12-  μ  m thickness to avoid sampling 
heterogeneity, with the exception of K and O, which are single confocal images from the stack. Bars, 10   μ  m.     JCB • VOLUME 181 • NUMBER 5 • 2008  854 
  How does the soluble form of the Flt-1 receptor impact 
vessel morphogenesis? The three major VEGF-A isoforms are 
hypothesized to have different spatial distributions in the extra-
cellular matrix that are important in regulating vessel morpho-
genesis, perhaps by formation of a gradient. In support of this 
model, mice expressing either only VEGF-A  120  , which lacks a 
heparin-binding domain, or VEGF-A  188  , with multiple heparin-
binding domains, have retinas with perturbed migration of vas-
cular tip cell fi  lopodia and aberrant vessel morphogenesis 
(  Ruhrberg et al., 2002  ;   Gerhardt et al., 2003  ). sFlt-1 contains a 
heparin-binding domain (  Park and Lee, 1999  ), and it also binds 
the extracellular matrix upon release from the endothelial cell 
in addition to binding and sequestering the VEGF-A ligand 
(  Orecchia et al., 2003  ). Thus, secreted Flt-1 may spread uni-
formly from the endothelial cell and, in a quantitative fashion, 
regulate the presentation of VEGF-A that is already established. 
In other developmental contexts, cells respond differentially 
to gradients of the same morphogen in specifi  c concentration 
ranges, so the interaction between VEGF-A and sFlt-1, even if 
quantitative, could change the morphogenetic response of the 
endothelial cell to VEGF-A (for review see   Ashe and Briscoe, 
2006  ). Alternatively, sFlt-1 might establish a countergradient or 
some other confi  guration that modulates VEGF-A presentation 
to endothelial cells qualitatively as well. We favor the latter 
model because it is consistent with the differences in   fl  t-1   locus 
expression and distribution of Flk-1 activation that we docu-
mented in developing vessels (  Fig. 9  ). In either scenario, the 
ability of sFlt-1 to move away from the endothelial cell after 
secretion is critical to its mechanism of action. 
  Filopodia form and extend from growing vascular cells 
into the extracellular matrix. Filopodia are involved in sensing 
the environment in other systems, such as guidance of the neuronal 
growth cone (for review see   Koleske, 2003  ). Analysis of retinal 
vessels indicates that endothelial tip cells differ from neigh-
boring endothelial stalk cells in the number of fi  lopodia and ex-
pression of marker genes, implicating fi  lopodia as transducers of 
positional information (  Gerhardt et al., 2003  ). Our data support 
and extend this model by revealing a required role for sFlt-1 in 
providing positional information. We found that Flk-1 activa-
tion, as measured by the phosphorylation of Tyr-1173, is not nor-
mally uniform in developing vessels, but it exhibits a mosaic 
pattern. In many cases, small groups of endothelial cells had 
higher levels of pFlk staining than neighboring endothelial cells, 
suggesting that these cells experience higher levels of Flk-1 acti-
vation. In contrast,   fl  t-1 
   /       mutant vessels had both higher levels 
and a more homogeneous distribution of pFlk staining, suggest-
ing that spatial information required for different levels of Flk-1 
activation in different endothelial cells is missing in the   fl  t-1 
   /      
mutant genetic background. This implies that Flt-1 provides that 
spatial information, at least in part. We found that a   lacZ   reporter 
gene inserted into the   fl  t-1   locus is expressed at different levels 
among endothelial cells of developing vessels. This fi  nding 
strongly suggests that endogenous Flt-1 RNA is also expressed 
heterogeneously in developing vessels, and it provides a starting 
point for a model of how heterogeneity of Flt-1 expression may 
lead to a mosaic pFlk signal (  Fig. 9  ). However, the ability of 
sFlt-1 but not mFlt-1 to rescue branching morphogenesis and the 
 Previously,  the   fl  t-1   genomic locus was modifi  ed in vivo 
to a locus that generated both sFlt-1 and mFlt-1 without the cyto-
plasmic domain (  Hiratsuka et al., 1998  ). This nonsignaling 
locus was compatible with embryonic vascular development, 
which is consistent with our data, but the role of individual Flt-1 
isoforms was not tested. Recently, the   fl  t-1   locus was modifi  ed 
in vivo to a locus that generated only the sFlt-1 isoform (  Hiratsuka 
et al., 2005  ). The resulting embryos were viable on certain 
genetic backgrounds and partially viable on others, suggesting 
that sFlt-1 is suffi  cient to promote proper vascular development 
in vivo in the appropriate genetic background. It is compelling 
that both genetic manipulation of the endogenous   fl  t-1   locus  and 
rescue via transgene expression of the different Flt-1 isoforms 
yield evidence that sFlt-1 has a critical role in vascular develop-
ment. Our data provide the fi  rst direct comparison of the ability 
of the different Flt-1 isoforms to rescue specifi  c aspects of vas-
cular development, and we show here that vessel branching is 
uniquely sensitive to the soluble isoform of the Flt-1 receptor. 
  Targeting of each Flt-1 isoform transgene independently 
to the   ROSA26   locus also allowed us to separate the effects of 
sFlt-1 and mFlt-1 on specifi  c parameters of vessel development. 
Our analysis revealed that sFlt-1 –  expressing clones were able to 
rescue vessel branching to signifi  cant levels, whereas the mFlt-1 
clones did not rescue vessel branching. In contrast, both Flt-1 
isoform transgenes rescued vessel area, endothelial cell num-
bers, and the endothelial mitotic index to equivalent levels. 
These fi  ndings suggest that differences between the two Flt-1 
isoforms are not relevant to the ability of Flt-1 to rescue endo-
thelial proliferation, but they are critical to the role of sFlt-1 in 
vessel branching morphogenesis. The major differences be-
tween the Flt-1 isoforms are that the soluble isoform cannot sig-
nal, but it can diffuse away from the endothelial cell and into the 
matrix (  Orecchia et al., 2003  ), whereas the membrane-tethered 
isoform cannot diffuse but can theoretically signal. However, 
our preliminary data show that mFlt-1 deleted for the cytoplas-
mic signaling domain has the same rescue profi  le as intact mFlt-1 
(unpublished data), as expected from the fi  nding that deleted 
mFlt-1 can support embryonic vascular development (  Hiratsuka 
et al., 1998  ). Thus, the differences in the ability to rescue vascu-
lar development between the two Flt-1 isoforms reside primar-
ily in the putative spatial location of the different isoforms. Flt-1 
can form heterodimers with Flk-1, although these interactions 
have been diffi  cult to analyze with receptors at endogenous 
levels (  Autiero et al., 2003  ;   Neagoe et al., 2005  ). However, if 
heterodimer formation is relevant during vascular development, 
the mFlt-1 isoform would presumably have an advantage in 
forming heterodimers over sFlt-1 because it is membrane local-
ized near Flk-1; therefore, this mechanism is unlikely to account 
for the increased effi  ciency of sFlt-1 in the rescue of vessel 
branching morphogenesis developmentally. Thus, the most likely 
model is that during vascular development, both Flt-1 isoforms 
act as ligand sinks to sequester VEGF-A, and this property is 
suffi  cient to regulate the amplitude of the VEGF signal and res-
cue endothelial proliferation independent of spatial context. 
However, the unique ability of sFlt-1 to leave the cell surface 
provides additional spatial regulation of VEGF signaling and 
rescues branching morphogenesis. 855  F  LT  -1 REGULATES VESSEL BRACHING SPATIALLY   •   Kappas et al.
(VEGFR-1) RNA was down-regulated with the loss of Notch-
Delta signaling in   Dll4 
+/        retinas, suggesting that under normal 
conditions, Notch-Delta signaling up-regulates Flt-1, and this 
regulation may contribute to the negative regulation of tip cell 
formation and sprouting mediated by Notch-Delta. In this sce-
nario, it is provocative to speculate that perhaps the spatial orga-
nization of Notch signaling infl  uences spatial VEGF signaling 
or vice versa. 
  Recently, the importance of the Flt-1 receptor in hemato-
poietic stem and progenitor cell function has been established. 
Both homing of hematopoietic progenitors and their ability to set 
up a niche for metastatic tumor cells in distant organs require 
Flt-1, and these functions are likely mediated via the signaling 
properties of the Flt-1 receptor (  Hattori et al., 2002  ;   Kaplan et al., 
2005  ). However, it has been diffi  cult to establish a physiological 
role for the soluble form of the Flt-1 receptor. It is implicated 
in the pathology of preeclampsia in pregnant women because 
sFlt-1 serum levels are elevated in women with the condition, 
but its exact role in this placental disease is not well understood 
(for review see   Maynard et al., 2005  ). A recent study in the eye 
showed that avascularity of the cornea, which allows for proper 
vision, results from the expression of soluble Flt-1 that binds 
VEGF-A protein (  Ambati et al., 2006  ). Our work shows that 
mosaic pattern of Flk-1 activation in sFlt-rescued   fl  t-1 
   /       mutant 
vessels indicates that only sFlt-1 critically regulates VEGF-A 
signaling that leads to proper vessel morphogenesis. We suggest 
that both sFlt-1 and mFlt-1 are expressed heterogeneously in 
developing vessels but that the impact of heterogeneous sFlt-1 
expression is amplifi  ed by its ability to leave the cell surface and 
affect VEGF availability to nearby cells (  Fig. 9, A and D  ). In con-
trast, the ability of mFlt-1 to induce heterogeneous Flk signaling 
is predicted to be cell autonomous and, thus, local and modest in 
comparison to the effects of sFlt-1 (  Fig. 9 C  ). 
  Although it is not completely clear how the discontinui-
ties of Flk-1 signaling that are formed as a result of sFlt-1 ex-
pression are achieved, it is interesting that a similar pattern of 
mosaic activation has recently been reported for the Notch sig-
naling pathway in developing vessels (  Hellstrom et al., 2007  ; 
  Hofmann and Luisa Iruela-Arispe, 2007  ). Expression of the 
Notch ligands Dll-4 (Deltalike 4) and Jagged were found in a 
mosaic pattern. The VEGF-A pathway appears to function both 
upstream and downstream of the Notch pathway in endothelial 
cells because VEGF signaling was required for Dll4 expression 
in tumors, and VEGF receptor expression was modulated in 
retinas heterozygous for Dll4 (  Noguera-Troise et al., 2006  ; 
  Suchting et al., 2007  ). Interestingly, in the latter study, Flt-1 
  Figure 9.       Model proposing a mechanism for differential Flt-1 isoform activity in Flk signaling and branching morphogenesis.   We propose a model in 
which Flt-1 secreted from endothelial cells modulates a VEGF-A gradient (greenish blue) to affect ligand availability based on the heterogenous expression 
of both Flt-1 isoforms in developing vessels. (A) In WT vessels, both mFlt-1 and sFlt-1 act as ligand sinks to modulate the amplitude of the VEGF signal to 
endothelial cells. The ability of sFlt-1 to be secreted leads to the modulation of pFlk signaling in neighboring cells as well. (B) In the absence of Flt-1, the 
VEGF-A gradient is not modulated either quantitatively or qualitatively, which leads to excess and more uniform pFlk signaling and aberrant proliferation 
and branching. (C) Expression of an mFlt-1 transgene reduces overall levels of pFlk signaling, but the pattern of pFlk activation remains more homogeneous 
because the mFlt-1 effects are cell autonomous and do not extend to neighboring cells. Thus, proliferation but not branching is rescued. (D) Expression of an 
sFlt-1 transgene also reduces overall levels of Flk-1 activation and modulates signal amplitude to rescue proliferation, but the ability of sFlt-1 to be secreted 
allows it to modulate ligand availability to nearby cells and thus restores more of the heterogeneity of pFlk staining and rescue branching. Green arrows 
denote sFlt-1 protein, green cups denote mFlt-1 protein, and red dots denote pFlk expression.     JCB • VOLUME 181 • NUMBER 5 • 2008  856 
medium (5% goat serum in PBS) for 1 h at 37  °  C, and all antibodies were 
diluted into staining medium. Cultures were incubated in phospho  –  VEGFR-2 
(Tyr-1175) rabbit antibody (19A10; Cell Signaling Technology) at 1:200 
overnight at 4  °  C and after PBS washes were incubated with goat anti  – 
rabbit IgG conjugated to AlexaFluor488 (Invitrogen) at 1:400 for 2 h at RT. 
Cultures were then incubated with rat anti  –  mouse Flk-1 antibody (BD Biosci-
ences) at 1:200 overnight at 4  °  C and with goat anti  –  rat IgG conjugated to 
AlexaFluor568 (Invitrogen) for 1 h at RT and rinsed in PBS. PECAM-stained 
cultures were viewed and photographed with an inverted microscope (IX-50; 
Olympus) outﬁ  tted with epiﬂ  uorescence using a 10  ×   NA 0.25 CPlan RT 
objective (Olympus) and a camera (DP71; Olympus) with DP Controller 
version 3.1.1.267 software (Olympus). Flk-1  –   and      -galactosidase  –  stained 
cultures were analyzed with a confocal microscope (LSM 5 PASCAL; Carl 
Zeiss, Inc.) using either a 40  ×   NA 1.3 EC Plan-Neoﬂ  uor oil objective (Carl 
Zeiss, Inc.) or a 100  ×   NA 1.4 plan-Apochromat oil objective (Carl Zeiss, 
Inc.) at RT using PASCAL Release version 4.2 SP1 acquisition software (Carl 
Zeiss, Inc.). For the      -galactosidase  –  stained cultures,     10 confocal images 
were acquired through 12   μ  m of thickness on the z axis and were combined 
and ﬂ   attened. Minor adjustments (brightness and contrast to the whole 
panel) were done using Photoshop CS2 (Adobe). 
  To quantify the vascular area labeled with PECAM antibody, 
PECAM-stained cultures were photographed and analyzed as described 
previously (  Kearney et al., 2002  ). In brief, four to six wells were ana-
lyzed for each genotype. For each well, six to eight images were ac-
quired sequentially for analysis. Percent PECAM area means for each 
well were calculated, and the mean of four wells for each clone was used 
to determine SD values. Branch point analysis was performed on similar 
images from PECAM-stained cultures as described previously (  Kearney 
et al., 2004  ). The mean branch point score from 8  –  12 pictures for each 
clone was used to determine SD values. All values were statistically ana-
lyzed using the two-tailed   t   test. Flk-1  –  stained cultures were analyzed by 
counting the number of total Flk-1  –  positive cells that also were positive for 
pFlk (Tyr-1173/1175) in representative areas. Quantitative analysis of 
the ratio of pFlk (Tyr-1173/1175) to total Flk staining was performed by 
outlining individual endothelial cells and using MetaMorph software 
(MDS Analytical Technologies) to calculate the ratio. 
  Mitotic index analysis 
  ES cell cultures were differentiated to day 8 and were ﬁ  xed and stained with 
antibodies to PECAM-1 and phosphohistone H3 as described previously 
(  Kearney et al., 2002  ). Nuclei were visualized with DRAQ 5 used according 
to the manufacturer  ’  s protocol (Biostatus Limited). Endothelial mitotic indices 
were determined from confocal images as described previously (  Kearney 
et al., 2002  ). Values were statistically compared using       
2   analysis. 
  Real-time RT-PCR 
  Real-time RT-PCR was performed as described previously (  Hazarika et al., 
2007  ). In brief, total RNA was extracted from cells using the Ribopure total 
RNA kit (Ambion) according to manufacturer  ’  s instructions. After DNase 
digestion, 1   μ  g of total RNA was reverse transcribed using the high capac-
ity cDNA Reverse Transcription kit (Applied Biosystems). 50 ng cDNA was 
ampliﬁ  ed in a Real-Time PCR System (model 7300; Applied Biosystems) 
using Taqman gene expression assays speciﬁ  c for mFlt-1 and sFlt-1 (custom-
designed Taqman assay; forward primer, 5     -GCAGAGCCAGGAACATATA-
CACA-3     ; reverse primer, 5     -GAGATCCGAGAGAAAATGGCCTTT-3     ; probe, 
CAGTGCTCACCTCTAACG). Each sample was run in duplicate, and the 
expression of target was normalized to endogenous 18S ribosomal RNA. 
Target copies were quantiﬁ  ed using the comparative threshold cycle relative 
quantitation method. Total RNA without reverse transcription was used as 
the nontemplate control. 
  Western blot analysis 
  Western blot analysis was performed as described previously with some 
modiﬁ  cations (  Roberts et al., 2004  ). In brief, day 8 ES cell cultures were 
lysed into radioimmunoprecipitation assay buffer supplemented with prote-
ase inhibitors. Lysates were centrifuged at 12,000   g   for 10 min, and super-
natants were separated on an 8% SDS-polyacrylamide gel. Gel transfer was 
to a polyvinylidene ﬂ  uoride membrane (GE Healthcare) under standard con-
ditions. The phospho-Flk signal was detected by incubation with antiphospho-
VEGFR2 (Tyr-1175; 1:500; Cell Signaling Technology) and HRP-labeled 
anti  –  mouse secondary antibody (1:5,000; GE Healthcare). Total Flk-1 was 
detected by using rat ant  –  mouse Flk-1 antibody (1:500; BD Biosciences) and 
HRP-labeled anti  –  rat secondary antibody (1:5,000; GE Healthcare). After 
detection by enhanced chemiluminescence (GE Healthcare), the results were 
quantiﬁ  ed by densitometry using ImageJ (National Institutes of Health). 
  soluble Flt-1 is also critical for proper vessel morphogenesis in 
developing vessels and suggests that sFlt-1 exerts its effects by 
spatial modulation of VEGF-A signaling. Thus, it seems likely 
that sFlt-1 acts as an endogenous modulator of blood vessel for-
mation in numerous physiological contexts. In some cases, its 
expression provides for the complete blockade of VEGF signaling, 
whereas in other contexts, its regulated activity modulates the 
presentation of VEGF-A to the developing vessel. Our increased 
knowledge of the antiangiogenic mechanisms used by nature to 
regulate blood vessel formation should aid in the development of 
rational therapies for vascular diseases. 
  Materials and methods 
  DNA constructs and electroporation 
  The PECAM promoter/intron enhancer was a gift from H. Scott Baldwin 
(Vanderbilt University, Nashville, TN), sFlt-1 cDNA was generated as de-
scribed previously (  Kearney et al., 2004  ), and mFlt-1 cDNA was a gift 
from G. Breier (University of Dresden, Dresden, Germany;   Breier et al., 
1995  ). Targeted insertion of the Flt-1 isoform transgene into the   ROSA26   
genomic locus (targeting vector was a gift from P. Soriano, Fred Hutchinson 
Cancer Research Center, Seattle, WA) was performed using Gateway Mul-
tiSite cloning vectors. The targeting vector pROSA26-1 was modiﬁ  ed by 
adding an MluI site into the lone restriction site of the multiple cloning site, 
XbaI. PacI was also added into the KpnI site of pROSA26-1. The resulting 
vector was designated modiﬁ  ed pROSA26-1. Modiﬁ  ed pROSA26-1 was 
next transformed into a Gateway destination vector. Three Gateway donor 
vectors were subsequently created. The ﬁ   rst one, pDONR P2R-P3, was 
made as two different vectors: one containing sFlt-1 cDNA and the other 
containing mFlt-1 cDNA. Each PCR product (sFlt-1 and mFlt-1 transgene) 
was recombined into pDONR P2R-P3 via attB sites to create pDONR 
P2R-P3  –  sFlt-1 and pDONR P2R-P3  –  mFlt-1. The PECAM promoter/intron 
enhancer was then ampliﬁ  ed, and the PCR product was recombined into 
pDONR-221 via attB sites to create pDONR221-PECAM. We next ampli-
ﬁ  ed a PGK-hygromycin cassette and recombined the PCR product into 
pDONR P4-P1R via attB sites to create pDONR P4-P1R-PGK-Hygro. Each Flt-1 
isoform-speciﬁ  c pDONR-P2R-P3  –  Flt-1 vector was combined with pDONR221-
PECAM, pDONR-P4-P1R-PGK-Hygro, and pROSA26-1      DEST R4-R3 to 
create pROSA26-1-PECAM  –  sFlt-1  –  Hygro and pROSA26-1-PECAM  –  mFlt-1  –
  Hygro. 15   μ  g of each pROSA26-1-PECAM  –  Flt-1  –  Hygro DNA was lin-
earized with PacI and electroporated into 2   ×   10 
7     ﬂ  t-1 
    /        ES cells using an 
electroporator (250 V/300   μ  F; GenePulser II; Bio-Rad Laboratories). Selection 
was in 200   μ  g/ml hygromycin B (Roche) for 12  –  14 d, and drug-resistant 
ES cell colonies were picked and expanded. Correct targeting into the 
  ROSA26   locus was conﬁ  rmed via PCR using forward primer 5     -CCTAAA-
GAAGAGGCTGTGCTTTGG-3      and reverse primer 5     -CCGATGGCTGTG-
TAGAAGTACTC-3     . 
  Cell culture and in vitro differentiation 
  WT ES cells,   ﬂ  t-1 
    /        ES cells (gift of G.-H. Fong, University of Connecticut 
Health Center, Farmington, CT), and   ﬂ  t-1 
    /        ES cells containing an sFlt-1 or 
mFlt-1 transgene linked to the PECAM promoter/intron enhancer element in 
the   ROSA26   locus (ROSA;Tg PECAM  –  sFlt-1 and ROSA;Tg PECAM  –  mFlt-1) 
were maintained and differentiated as described previously (  Bautch et al., 
1996  ;   Kearney and Bautch, 2003  ). Embryoid bodies were plated onto 
either slide ﬂ  asks (Thermo Fisher Scientiﬁ  c) or wells of a 24-well tissue cul-
ture dish at day 3 of differentiation and cultured at 37  °  C in 5% CO  2   until 
day 8, when cultures were ﬁ  xed and analyzed. 
  Antibody staining and quantitative image analysis 
  Day 8 ES cell cultures were rinsed with PBS and ﬁ  xed for 5 min in ice-cold 
methanol-acetone (50:50) for PECAM or      -galactosidase staining or 4% 
PFA in PBS for Flk-1 staining. For PECAM staining, ﬁ  xed cultures were re-
acted with rat anti  –  mouse PECAM at 1:1,000 (MEC 13.3; BD Biosciences) 
and donkey anti  –  rat IgG (IgG; H+L) TRITC at 1:100 (Jackson Immuno-
Research Laboratories) or goat anti  –  rat conjugated to AlexaFluor488 (IgG; 
H+L) at 1:200 (Invitrogen) as described previously (  Bautch et al., 2000  ). 
For      -galactosidase staining, cultures were reacted with rabbit polyclonal 
anti  –       -galactosidase at 1:300 (Cappel Laboratories) and donkey anti  –  rabbit 
IgG (IgG; H+L) TRITC at 1:100 (Jackson ImmunoResearch Laboratories). 
For Flk-1 and pFlk (Tyr-1173/1175) staining, cultures were blocked in staining 857  F  LT  -1 REGULATES VESSEL BRACHING SPATIALLY   •   Kappas et al.
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